retatrutide dosing in clinical trials trial frequency Retatrutide Dosing Guide: 2mg–12mg Protocol + Calculator retatrutide clinical trial dosing schedule

doi:10.1016/j.cmet.2007.03.006 75

co-funded with EU funds from FEDER Program)

The GLP-1/glucagon agonist cotadutide (MEDI0382) is the compound of this dual-receptor agonist class that is the most advanced in clinical development

It is still in late-stage clinical trials, so the exact doses and official prescribing schedule havent been finalised

ZieliskiKPuksztaSMickiewiczMKotlarzMWygockiPZieleMet al

The involvement of GLP-1 in PD can be simplified to the activation of the MAPK/extracellular signal-regulated kinase 1/2 (ERK) pathway, which has an important role in synaptic plasticity, and the PI3K/Akt pathway signaled by GLP-1 receptor stimulation and the subsequent increase in cAMP and PKA and PI3K activation [73]